Welcome to LiVDerm
Where the Constellations of Medical Dermatology and Aesthetics Collide
Led by world-renowned experts in the field, LiVDerm is a comprehensive dermatologic hub where medical professionals educate, collaborate, and engage.
LiVDerm’s mission is to boldly advance higher standards of dermatology care through live and virtual educational offerings, resources for providers, students and patients, and much more.
As a leading source for the latest therapies, technologies, procedures, and practice guidelines in medical and aesthetic dermatology, LiVDerm empowers providers to manage dermatologic conditions with confident authority. With a multipronged focus on the myriad specialties within the field, LiVDerm provides innovative and integrated education across the dermatology spectrum.
Upcoming Live Events
- February 8- 9 , 2024
- Miami Beach, FL
- February 10, 2024
- Miami Beach, FL
Complimentary Continuing Education
Hidradenitis Suppurativa
Virtual Symposium
Timely Management of HS: Addressing Barriers to Care for Patients in Need
Alopecia Areata
Virtual Symposium
Gamechangers in Alopecia Areata: Targeted Therapies for Patient-Centered Care
Psoriasis
Virtual Symposium
A New Age in Pediatric Psoriasis: Case-Based Learning for Inclusive Care
Atopic Dermatitis
Virtual Symposium
Infants and Atopic Dermatitis: The Biggest Help for the Smallest Patients
Rare Diseases
Clinical Brief
Updates in Managing Rare Diseases: Tips for the Practicing Dermatologist
Alopecia Areata
Webcast
PRIMER: Gamechangers in Alopecia Areata: Targeted Therapies for Patient-Centered Care
Psoriasis
Virtual Symposium
Managing Psoriatic Arthritis Together: A Multidisciplinary Approach to Care Between Rheumatologists and Dermatologists
Live Conference On-Demand
Deep Dive
The Gut-Skin Connection: The Microbiome and Its Effects on the Skin
LivDerm Articles
International Vitiligo Task Force Publishes New Guidelines
The treatment and management of vitiligo can be challenging for both patients and their providers. Vitiligo carries a significant disease burden, both physically and mentally.…
Study Evaluates Prevalence of Allergic Contact Dermatitis in Children with and without AD
A recent study published in the Journal of the American Academy of Dermatology sought to evaluate the prevalence of allergic contact dermatitis (ACD) in children…
The Impact of Hyperhidrosis on Quality of Life
Hyperhidrosis (HH) is a condition characterized by excessive sweating beyond what is necessary for thermoregulation and affects millions of people worldwide. It can be a…
First IL-17 A Inhibitor for Hidradenitis Suppurativa Approved by FDA
Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved Cosentyx® (secukinumab) for the treatment of moderate-to-severe hidradenitis suppurativa (HS) in adults.…
FDA Approves Triple Combination IDP-126 (Cabtreo™) for Acne
Bausch Health has announced that the U.S. Food and Drug Administration (FDA) has approved IDP-126 (Cabtreo™) for the treatment of acne in patients aged 12…
FDA Approves Bimekizumab for Moderate-to-Severe Plaque Psoriasis
The U.S. Food and Drug Administration (FDA) has approved BIMZELX® (bimekizumab-bkzx) for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic…
AbbVie Announces Upadacitinib Meets Primary Endpoint of Phase 2 Trial for Vitiligo - Advances to Phase 3
AbbVie recently announced that its phase 2b study evaluating upadacitinib (RINVOQ®) for the treatment of adults with nonsegmental vitiligo (NSV) met the primary endpoint of…
FDA Approves Arcutis’ Roflumilast Cream 0.3% for Plaque Psoriasis in Children Aged 6 to 11 Years
Arcutis Biotherapeutics recently announced that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) for the expanded indication of ZORYVE…
Study Reports Colloidal Oatmeal Effective at Improving Atopic Dermatitis in Black Children
Kenvue recently revealed that an over-the-counter (OTC) moisturizer containing 1% colloidal oatmeal was shown to be effective in improving Eczema Area and Severity Index (EASI)…
Hidradenitis Suppurativa May Involve Local Changes in the Skin
In a recent study, researchers aimed to characterize somatosensory profiles in patients with hidradenitis suppurativa (HS) at clinically affected and nonaffected areas compared with pain-free…
Arcutis Announces Positive Long-Term Results of Roflumilast Cream 0.15%
Arcutis Biotherapeutics recently announced the interim results of its phase 3, long-term extension trial of roflumilast cream 0.15% for the treatment of atopic dermatitis (AD)…
Optimizing Acne Treatment Using Ceramide-Containing Skincare
Early in 2023, a group of nine dermatologists met to review and discuss the current literature on acne to understand both the socioeconomic and psychological…
Study Evaluates Effects of Age and Sex on Alopecia Areata Comorbidities
Researchers sought to clarify the association between age and sex with various comorbidities in patients with alopecia areata.
Meet Karan Lal, DO, MS, Featured Speaker at SBS: West Coast Derm
Karan Lal, DO, MS, is a double-board-certified dermatologist who specializes in adult, pediatric, and cosmetic dermatology. His impressive educational background serves as a demonstration of…
Study Shows Supplement Containing Amino Acid May Improve Efficacy of Hair Loss Treatments
Study evaluates efficacy of oral supplement containing hydrolyzed collagen and amino acids with drug treatments in patients with hair loss.
Launch of New Hair Regrowth Serum with Exosomes
ExoCel Bio™ has announced the launch of Refine, their new Exovex™ serum with a 75 billion concentration of exosomes, designed for hair regrowth. This high…
Study Shows Dupilumab Successful in Treating Bullous Pemphigoid
A recent retrospective cohort study revealed that dupilumab was successful in treating bullous pemphigoid (BP). The study, which was conducted from Jan. 1, 2021, to…
Ava T. Shamban, MD at SBS: West Coast Derm
Ava T. Shamban, MD, is a board-certified dermatologist with over 20 years of experience in the field. A scientist, researcher, and business owner, Dr. Shamban’s…
Risankizumab Demonstrates Superior Efficacy in Treating Plaque Psoriasis as Compared to Apremilast in Phase 4 Study
In a recent study published in the British Journal of Dermatology, it was found that for patients with moderate psoriasis, treatment with risankizumab demonstrated superior…
Study Shows Combining Glycyrrhizin Tablets with 308 nm Excimer Laser Effective in Treating Vitiligo
During a recent systematic review, researchers determined that compound glycyrrhizin tablets combined with the 308 nm excimer laser proved more effective in treating vitiligo than…
LivDerm Podcasts
Updates in JAK Inhibitor Therapies for Alopecia Areata with Brett King, MD
Nuanced Treatment of Pediatric Alopecia Areata with Brittany Craiglow, MD
Navigating the Expanding Treatment Landscape for Pediatric Patients with Atopic Dermatitis
Pearls for Early and Accurate Diagnosis of Infantile Atopic Dermatitis
Improving Communication and Shared Decision-Making with Caregivers of Patients with Atopic Dermatitis
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
Dermatologic Care in the Sexual and Gender Diverse Patient with Klint Peebles, MD
The Latest Advances in Cosmetic Dermatology with Doris J. Day, MD
The Latest Advances with Energy-Based Devices and Scar Treatments with Michael H. Gold, MD, FAAD
Anatomy Matters: The Cadaver Lab Experience with Z. Paul Lorenc, MD
Finding the Fountain of Youth: How Light Keeps Your Skin Glowing
Connect With Us
Looking for more information on our educational opportunities? Please fill out the form below to be contacted by one of our education advisors.
